IL37 and type 1 diabetes mellitus: Here, IL-37 decreased in anti-RV IgG (ND− and ND+) with nonsignificance compared to control, a finding that agreed with that by reported by Harms et al. [45], who revealed that IL-37 levels showed a nonsignificant difference between control and T1D populations but increased in anti-RV IgG (PD− and PD+ compared to control, ND−, and ND+).